Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Scott A. Tetreault"'
Autor:
Ian W. Flinn, Lori Steelman, Andrew R. Pettitt, Scott D. Lunin, Eric D. Jacobsen, Ngoc Diep Le, Sven de Vos, Pier Luigi Zinzani, David T. Weaver, Kirit M. Ardeshna, Zoltán Zsolt Nagy, Michele Merli, Virginia Kelly, Jiri Mayer, Sarit Assouline, Michael Crump, Scott A. Tetreault, Nina D. Wagner-Johnston, Karem Etienne Abou-Nassar, Carole B. Miller, Stephanie Lustgarten, Weiliang Shi, Olivier Tournilhac
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2019, 37 (11), pp.912-922. ⟨10.1200/JCO.18.00915⟩
JOURNAL OF CLINICAL ONCOLOGY
Journal of Clinical Oncology, American Society of Clinical Oncology, 2019, 37 (11), pp.912-922. ⟨10.1200/JCO.18.00915⟩
JOURNAL OF CLINICAL ONCOLOGY
PURPOSE Indolent non-Hodgkin lymphoma (iNHL) remains largely incurable and often requires multiple lines of treatment after becoming refractory to standard therapies. Duvelisib was approved by the Food and Drug Administration for relapsed or refracto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305ab52e5809eb402deb5f26b6e51863
https://hal.archives-ouvertes.fr/hal-02102882
https://hal.archives-ouvertes.fr/hal-02102882
Autor:
Pier Luigi Zinzani, Carole B. Miller, Stephanie Lustgarten, Kam Sprott, NgocDiep Le, Jonathan A. Pachter, Ian W. Flinn, Kirit M. Ardeshna, David T. Weaver, Nina D. Wagner-Johnston, Scott A. Tetreault
Publikováno v:
Blood. 132:4167-4167
Introduction: Indolent NHL (iNHL) remains largely incurable, with the majority of patients (pts) eventually becoming refractory to standard therapies, necessitating new effective and tolerable treatments. Duvelisib is an oral dual PI3K-δ,γ inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d83382187b5f71487fec9287e9d20db
https://doi.org/10.1182/blood-2018-99-117903
https://doi.org/10.1182/blood-2018-99-117903
Publikováno v:
Oncology (Williston Park, N.Y.). 27(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d465706d788a59e135607e971d87127
https://pubmed.ncbi.nlm.nih.gov/23977753
https://pubmed.ncbi.nlm.nih.gov/23977753
Autor:
Scott D. Lunin, Teresa A. Coleman, Karen Dewar, Patricia Pimental, David Wright, Lori Steelman, James Essell, Charles D. Webb, Robert M. Langdon, Ian Flinn, Donald K Strickland, Nina D. Wagner-Johnston, Mike Marris, Nadim F. Nimeh, Charles M. Farber, Patrick Kelly, Scott A. Tetreault
Publikováno v:
Journal of Clinical Oncology. 32:TPS8619-TPS8619
TPS8619 Background: Phosphoinositide 3-kinase (PI3K)-δ,γ isoforms are preferentially expressed in leukocytes, have significant roles in normal B and T cell function, and are central to the growth a...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8403eedafe8d5444ce9fb4451d86e003
https://doi.org/10.1200/jco.2014.32.15_suppl.tps8619
https://doi.org/10.1200/jco.2014.32.15_suppl.tps8619
Autor:
Scott A. Tetreault, Alan Saven
Publikováno v:
Leukemialymphoma. 37(1-2)
Therapeutic options for patients with Waldenström macroglobulinemia (WM) now include the purine nucleoside analogues, fludarabine and cladribine. Both these agents have been associated with the onset of severe life-threatening autoimmune hemolytic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49baef854ad63d78b0a8f4766cebf5e5
https://pubmed.ncbi.nlm.nih.gov/10721776
https://pubmed.ncbi.nlm.nih.gov/10721776
Autor:
Ian W. Flinn, Pedro Santabarbara, Michael Crump, O. Tournilhac, Eric D. Jacobsen, Lori Steelman, Nina D. Wagner-Johnston, Karim Abou-Nassar, Michele Merli, Andrew R. Pettitt, Scott D. Lunin, Pier Luigi Zinzani, Kirit M. Ardeshna, Weiliang Shi, Jiri Mayer, Scott A. Tetreault, Carole B. Miller, Zsolt Nagy, Sarit Assouline, Sven de Vos
Publikováno v:
Publons
DYNAMO: A Phase 2 Study Demonstrating the Clinical Activity of Duvelisib in Patients with Relapsed Refractory Indolent Non-Hodgkin Lymphoma Introduction: Indolent non-Hodgkin lymphoma (iNHL) is characterized by a relapsing clinical course with shorte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a3545442454412afd0ba73636bbfd0
https://publons.com/publon/27420065/
https://publons.com/publon/27420065/